B2TM01 AF NFT

Ribosomal protein L11 methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifftmio3rpigsab2dkzi2yte6r4r2xryxxbqrx45jfzou6l4a3ddy/metadata.json
IPFS of structure file: 
bafybeiczwovubvez3jhklzqr54fgbqvj7iiobi55qptuwtsmgzbpsyfway/AF-B2TM01-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7B1Fbdc7c90598A502d8d8d5Dd726e011d0DC455
First NFT owner address (bech32): 
genesis10v0mm37fqkv22qkcmr2a6unwqywsm3z48u6p5y
Current NFT ID #309098 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
309098
Accession (UniProt):
B2TM01
Name::
Ribosomal protein L11 methyltransferase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TM01 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TM01|PRMA_CLOBB Ribosomal protein L11 methyltransferase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=prmA PE=3 SV=1 MNGVWIEVRVITSCEAIEPISGIFYGLNSQGVAVEDPNDLLTRDQGPLTWDFADINVLEHKGEFAVVKAYFSGDDDLEKIVSITKEKVKEIQEMGIDIGKGIVECDKIKEEDWANNWKKYYKPSNITDRIVVKPMWEEYSPKNEELVIELDPGMAFGTGTHETTRMCVKALEKYVEHDSTVFDVGCGSGILAIAAAKLGAKLALGVDLDPVAVESAKENVGLNDLDNIEILEGNLLDVIDGKADIVVANIIAEIICILTDDVSKALNKGGLFITSGIIHERVDMVTSKLDECGFEVMEVNKDGEWNCIVAKLK